Literature DB >> 34726580

Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines.

Qian-Qian Du1, Wei Shi1, Dan Yu1, Kai-Hu Yao1.   

Abstract

The universal administration of pneumococcal conjugate vaccines (PCVs) had been demonstrated as an effective way to prevent Streptococcus pneumoniae infection. However, the immunity induced by PCVs protected against the infections caused by vaccine serotypes, which were usually more frequent than non-vaccine serotypes (NVTs). The prevalence and pathogenicity of NVTs after universal vaccination have caused widespread concern. We reviewed the epidemiology of non-PCV13 S. pneumoniae before and after PCV13 introduction, and explored the potential reasons for the spread of NVTs. Emerging and spreading NVTs can be regarded as the focus for future serotype epidemiological survey and vaccine optimization.AbbreviationsIPD: invasive pneumococcal disease PCV: pneumococcal conjugate vaccines VT: vaccine serotypeNVT: non-vaccine serotype.

Entities:  

Keywords:  Streptococcus pneumoniae; invasive pneumococcal disease; non-vaccine serotype; pneumococcal conjugate vaccines; serotype replacement

Mesh:

Substances:

Year:  2021        PMID: 34726580      PMCID: PMC8903918          DOI: 10.1080/21645515.2021.1985353

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  96 in total

1.  One cross-sectional investigation revealed that non-vaccine serotypes of Streptococcus pneumoniae could be identified more frequently in elderly Chinese people.

Authors:  Qian-Qian Du; Hai-Lin Zeng; Lin Yuan; Ping Tang; Wei Gao; Jiao-Jiao Xu; Wei Shi; Tian Leng; Kuan-Xiu Hu; Kai-Hu Yao
Journal:  Vaccine       Date:  2021-05-09       Impact factor: 3.641

2.  Invasive pneumococcal disease and serotype emergence in the Auckland region during the vaccine era 2009-16.

Authors:  Nick Eichler; Edwin Reynolds; Catherine Jackson; Simon Thornley; Julia Peters
Journal:  J Prim Health Care       Date:  2019-04

3.  Relating Pneumococcal Carriage Among Children to Disease Rates Among Adults Before and After the Introduction of Conjugate Vaccines.

Authors:  Daniel M Weinberger; Lindsay R Grant; Robert C Weatherholtz; Joshua L Warren; Katherine L O'Brien; Laura L Hammitt
Journal:  Am J Epidemiol       Date:  2016-05-02       Impact factor: 4.897

4.  Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales.

Authors:  Bruno Pichon; Shamez N Ladhani; Mary P E Slack; Anne Segonds-Pichon; Nick J Andrews; Pauline A Waight; Elizabeth Miller; Robert George
Journal:  J Clin Microbiol       Date:  2012-12-26       Impact factor: 5.948

Review 5.  Development of pneumococcal vaccines over the last 10 years.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Expert Opin Biol Ther       Date:  2017-10-12       Impact factor: 4.388

6.  A New Pneumococcal Capsule Type, 10D, is the 100th Serotype and Has a Large cps Fragment from an Oral Streptococcus.

Authors:  Feroze Ganaie; Jamil S Saad; Lesley McGee; Andries J van Tonder; Stephen D Bentley; Stephanie W Lo; Rebecca A Gladstone; Paul Turner; Jeremy D Keenan; Robert F Breiman; Moon H Nahm
Journal:  mBio       Date:  2020-05-19       Impact factor: 7.867

Review 7.  Pneumonia and Streptococcus pneumoniae vaccine.

Authors:  Gyu-Lee Kim; Seung-Han Seon; Dong-Kwon Rhee
Journal:  Arch Pharm Res       Date:  2017-07-22       Impact factor: 4.946

8.  Efficacy of a Protein Vaccine and a Conjugate Vaccine Against Co-colonization with Vaccine-type and Non-vaccine Type Pneumococci in Mice.

Authors:  Gabriela Bc Colichio; Giuliana S Oliveira; Tasson C Rodrigues; Maria Leonor S Oliveira; Eliane N Miyaji
Journal:  Pathogens       Date:  2020-04-10

9.  New Strategy Is Needed to Prevent Pneumococcal Meningitis.

Authors:  Reshmi Mukerji; David E Briles
Journal:  Pediatr Infect Dis J       Date:  2020-04       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.